| Individual patient characteristics . | ASC-enriched side (R/L) . | Injected fat graft volume (mL) . | Fat graft retention at 12 months (%) . | |
|---|---|---|---|---|
| . | . | . | ASC-enriched . | Control . |
| Participant 1 | R | 300 | 64 | 70 |
| Participant 2 | R | 300 | 83 | 81 |
| Participant 3 | R | 300 | 4 | 6 |
| Participant 4 | L | 300 | 28 | 15 |
| Participant 5 | R | 350 | 70 | 70 |
| Participant 6 | R | 300 | 84 | 111 |
| Participant 7 | L | 330 | 83 | 81 |
| Participant 8 | L | 300 | 23 | 22 |
| Participant 9 | L | 320 | 14 | 14 |
| Participant 10 | L | 300 | 87 | 89 |
| Mean (95% CI) | – | 300 (300-315)a | 54.0 (30.4-77.6) | 55.9 (28.9-82.9) |
| Individual patient characteristics . | ASC-enriched side (R/L) . | Injected fat graft volume (mL) . | Fat graft retention at 12 months (%) . | |
|---|---|---|---|---|
| . | . | . | ASC-enriched . | Control . |
| Participant 1 | R | 300 | 64 | 70 |
| Participant 2 | R | 300 | 83 | 81 |
| Participant 3 | R | 300 | 4 | 6 |
| Participant 4 | L | 300 | 28 | 15 |
| Participant 5 | R | 350 | 70 | 70 |
| Participant 6 | R | 300 | 84 | 111 |
| Participant 7 | L | 330 | 83 | 81 |
| Participant 8 | L | 300 | 23 | 22 |
| Participant 9 | L | 320 | 14 | 14 |
| Participant 10 | L | 300 | 87 | 89 |
| Mean (95% CI) | – | 300 (300-315)a | 54.0 (30.4-77.6) | 55.9 (28.9-82.9) |
L, left; R, right.
aMedian (interquartile range).
| Individual patient characteristics . | ASC-enriched side (R/L) . | Injected fat graft volume (mL) . | Fat graft retention at 12 months (%) . | |
|---|---|---|---|---|
| . | . | . | ASC-enriched . | Control . |
| Participant 1 | R | 300 | 64 | 70 |
| Participant 2 | R | 300 | 83 | 81 |
| Participant 3 | R | 300 | 4 | 6 |
| Participant 4 | L | 300 | 28 | 15 |
| Participant 5 | R | 350 | 70 | 70 |
| Participant 6 | R | 300 | 84 | 111 |
| Participant 7 | L | 330 | 83 | 81 |
| Participant 8 | L | 300 | 23 | 22 |
| Participant 9 | L | 320 | 14 | 14 |
| Participant 10 | L | 300 | 87 | 89 |
| Mean (95% CI) | – | 300 (300-315)a | 54.0 (30.4-77.6) | 55.9 (28.9-82.9) |
| Individual patient characteristics . | ASC-enriched side (R/L) . | Injected fat graft volume (mL) . | Fat graft retention at 12 months (%) . | |
|---|---|---|---|---|
| . | . | . | ASC-enriched . | Control . |
| Participant 1 | R | 300 | 64 | 70 |
| Participant 2 | R | 300 | 83 | 81 |
| Participant 3 | R | 300 | 4 | 6 |
| Participant 4 | L | 300 | 28 | 15 |
| Participant 5 | R | 350 | 70 | 70 |
| Participant 6 | R | 300 | 84 | 111 |
| Participant 7 | L | 330 | 83 | 81 |
| Participant 8 | L | 300 | 23 | 22 |
| Participant 9 | L | 320 | 14 | 14 |
| Participant 10 | L | 300 | 87 | 89 |
| Mean (95% CI) | – | 300 (300-315)a | 54.0 (30.4-77.6) | 55.9 (28.9-82.9) |
L, left; R, right.
aMedian (interquartile range).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
